Kuros Biosciences AG/ CH0325814116 /
| 11/15/2024 5:18:12 PM | Chg. -6.45 | Volume | Bid5:20:00 PM | Ask5:20:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 25.00CHF | -20.51% | 28,769 Turnover: 788,496.70 |
-Bid Size: - | -Ask Size: - | 912.21 mill.CHF | - | - |
Assets
|
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
2022 IFRS in mill. CHF |
2023 IFRS in mill. CHF |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | .5000 | .5000 | .6000 | .7000 | 2.6420 | ||||||
| Intangible Assets | 27.9000 | 23.7000 | 22.6000 | 19.4100 | 16.5080 | ||||||
| Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | - | - | ||||||
| Fixed Assets | 64.6000 | 60.4000 | 58.4000 | 51.5500 | 44.2700 | ||||||
| Inventories | .5000 | .5000 | .5000 | 3.1700 | 4.8560 | ||||||
| Accounts Receivable | - | - | - | 2.8200 | 6.4110 | ||||||
| Cash and Cash Equivalents | 20.8000 | 28.4000 | 28.6000 | 24.0700 | 14.2080 | ||||||
| Current Assets | 23.3000 | 34 | 32.9000 | 31.3900 | 27.1940 | ||||||
| Total Assets | 87.9000 | 94.4000 | 91.3000 | 82.9500 | 71.4640 | ||||||
Liabilities
|
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
2022 IFRS in mill. CHF |
2023 IFRS in mill. CHF |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1.1000 | .9000 | .9000 | 1.3000 | 1.3010 | ||||||
| Long-term debt | - | - | - | - | 0.0000 | ||||||
| Liabilities to Banks | 0.0000 | 0.0000 | 6.5000 | - | - | ||||||
| Provisions | 2.3000 | 2.7000 | 3.4000 | .1000 | 0.0000 | ||||||
| Liabilities | 10 | 9.8000 | 14.4000 | 14.0900 | 14.7520 | ||||||
| Share Capital | 22.5000 | 32.8000 | 3.3000 | - | 3.6780 | ||||||
| Total Equity | 77.9000 | 84.6000 | 77 | 68.8600 | 56.7120 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 87.9000 | 94.4000 | 91.3000 | 82.9500 | 71.4640 | ||||||
Income Statement
|
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
2022 IFRS in mill. CHF |
2023 IFRS in mill. CHF |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 2.6000 | 4 | 13.8000 | 17.9900 | 33.5640 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -11.4000 | -13.4000 | -18.8000 | -13.4500 | -13.1920 | ||||||
| Interest Income | - | - | - | -2.5500 | -.2150 | ||||||
| Income Before Taxes | -11.8000 | -12.1000 | -9.6000 | - | - | ||||||
| Income Taxes | .5000 | .6000 | 2.1000 | -1.4000 | .3800 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -11.3000 | -11.5000 | -7.5000 | -14.6000 | -13.7270 | ||||||
Per Share
Cash Flow
|
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
2022 IFRS in mill. CHF |
2023 IFRS in mill. CHF |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -10.8000 | -9.2000 | -5.5000 | -7.3500 | -8.8440 | ||||||
| Cash Flow from Investing Activities | -.1000 | -.2000 | -.4000 | -.4000 | -.3260 | ||||||
| Cash Flow from Financing | 13.1000 | 17.1000 | 6.1000 | 3.2200 | -.1710 | ||||||
| Decrease / Increase in Cash | 2.2000 | 7.6000 | .3000 | - | - | ||||||
| Employees | 6 | 5 | 6 | 66 | 80 | ||||||
